Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
The Visby Medical Sexual Health Click Test is the first instrument-free PCR test for the detection of Chlamydia, Gonorrhea and Trichomonas, with results available within 30 minutes, during the patient visit SAN JOSE, Calif., Aug. 30, 2021 -- (Healthcare... Diagnostics, FDA Visby Medical, sexually transmitted infection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2021 Category: Pharmaceuticals Source Type: news
How Common are Co-infections with Trichomonas and Bacterial Vaginosis?
Discussion Vulvovaginitis is a common gynecological complaint for females of all ages. It is specifically the inflammation of the vulva and vagina but is used as a general term often to mean vulvar irritation, itching, and burning that can occur with or without vaginal discharge. In prepubertal females there is lack of estrogenization, and less lactobacillus species which creates a more neutral pH (normal vaginal pH is 20%. BV is caused by a change in the normal vaginal flora with a decrease in lactobacillus and an overgrowth of facultative anaerobic organisms. These organisms include Garnerella vaginalis, Atopobium vagina...
Source: PediatricEducation.org - May 24, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval ...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news
UCLA microbiologist Patricia J. Johnson elected to National Academy of Sciences
Patricia J. Johnson, UCLA professor of microbiology, immunology and molecular genetics, was elected to the National Academy of Sciences in recognition of her “distinguished and continuing achievements in original research.”Membership in the academy is one of the highest honors that a U.S. scientist can receive. Its members have included Albert Einstein, Thomas Edison, Orville Wright and Alexander Graham Bell. The academy today announced the election of 100 new members and 25 foreign associates.“I am very honored to be include among the ranks of such distinguished scientists,” said Johnson, who has a...
Source: UCLA Newsroom: Health Sciences - April 30, 2019 Category: Universities & Medical Training Source Type: news
Drink more black tea to prevent this common sexually transmitted disease
(Natural News) A study conducted by the U.S. Department of Agriculture (DA) found that drinking more black tea will protect against trichomoniasis, one of the world’s most prevalent sexually transmitted diseases (STDs). This is due to protective compounds in the tea that can inhibit the parasite’s growth. Trichomoniasis is caused by the protozoan Trichomonas vaginalis. It renders people... (Source: NaturalNews.com)
Source: NaturalNews.com - October 27, 2018 Category: Consumer Health News Source Type: news
Seven-Day Metronidazole Better for Trichomoniasis Tx in Women
WEDNESDAY, Oct. 17, 2018 -- A seven-day dose of metronidazole is associated with a reduced likelihood of being Trichomonas vaginalis-positive at test-of-cure compared with single-dose treatment, according to a study published online Oct. 5 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 17, 2018 Category: Pharmaceuticals Source Type: news
Pelvic Exam in ER Doesn't Help Predict STI for Young Females
TUESDAY, July 10, 2018 -- Pelvic examination does not increase the sensitivity or specificity for diagnosis of chlamydia, gonorrhea, or trichomonas over taking a history alone for young female patients presenting to the emergency department with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2018 Category: Pharmaceuticals Source Type: news
Using proteomics to understand pathogens
(American Society for Biochemistry and Molecular Biology) Recent studies in the journal Molecular& Cellular Proteomics have shed light on pathogenic mechanisms of the sexually-transmitted parasite Trichomonas vaginalis and the HIV-associated opportunistic lung fungus Aspergillus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2018 Category: International Medicine & Public Health Source Type: news
Large racial and ethnic disparity in world's most common STI
(Johns Hopkins Medicine) In a new Johns Hopkins study, researchers have added to evidence that Trichomonas vaginalis (TV), the world's most common curable sexually transmitted infection (STI), disproportionately affects the black community. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2018 Category: International Medicine & Public Health Source Type: news
The STD You've Probably Never Heard Of
The Basics Trichomoniasis (trich) is a common STI caused by a tiny parasite called Trichomonas vaginalis. An estimated 3.7 million people are infected, but because only about 30 percent show symptoms, most people don't know they have it until they get a positive test result. How You Get It The parasite gets passed during unprotected vaginal sex (can be from penis to vagina, vagina to penis, or vagina to vagina). Trich usually doesn't affect other areas, like the mouth or anus, which means this is one STD that is relatively uncommon for gay and bisexual men. What's It Like? Here's where the not-fun part comes in: When trich...
Source: Healthy Living - The Huffington Post - November 7, 2016 Category: Consumer Health News Source Type: news
Update on Laboratory Diagnosis and Epidemiology of Trichomonas vaginalis: You Can Teach an “Old” Dog “New” Trichs
Past viewpoints on Trichomonas vaginalis infection have characterized the associated clinical disease as a “nuisance” condition, with affected demographics largely being older African American females residing in urban centers. The advent of commercial molecular assays specific for T. vaginalis has offered a new outlook on trichomoniasis. Within high-prevalence sexually transmitted infection populati ons, parasite distribution is not localized to specific population centers, and T. vaginalis prevalence is elevated among both younger and older age groups. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - October 7, 2016 Category: Microbiology Authors: Erik Munson, Maureen Napierala, Kimber L. Munson Source Type: news
Trichomonas vaginalis Infection Among Homeless Adult WomenTrichomonas vaginalis Infection Among Homeless Adult Women
What is the prevalence of Trichomonas vaginalis infection among homeless women? Sexually Transmitted Infections (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2016 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Synedgen’s Director for Pharmaceutical Manufacturing Publishes New...
Study suggests that anti-retroviral lectins have a modest potential for preventing or treating Trichomonas infections(PRWeb September 01, 2015)Read the full story at http://www.prweb.com/releases/2015/09/prweb12934948.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 1, 2015 Category: Pharmaceuticals Source Type: news
Class II Special Controls Guideline: Nucleic Acid Amplification Assays for the Detection of Trichomonas vaginalis - Guideline for Industry and Food and Drug Administration Staff
This guideline identifies measures that FDA believes will mitigate the risks to health associated with these devices and provide a reasonable assurance of safety and effectiveness. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - August 18, 2015 Category: Medical Equipment Source Type: news
Federal Register: Medical Devices; Immunology and Microbiology Devices; Classification of Trichomonas Vaginalis Nucleic Acid Assay
The FDA is classifying a Trichomonas vaginalis nucleic acid assay into class II (special controls). The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - August 4, 2015 Category: Medical Equipment Source Type: news
Bristol undergraduates publish parasite research
A team of University of Bristol undergraduates have published a study on genetic diversity in the sexually transmitted parasite Trichomonas vaginalis that they carried out as part of project work for their degrees in the School of Biological Sciences. (Source: University of Bristol news)
Source: University of Bristol news - July 28, 2015 Category: Universities & Medical Training Tags: Research; Faculty of Science, Faculty of Science, School of Biological Sciences; Press Release Source Type: news
Could sex with 21 women 'cut prostate risk'?
"Sleeping with more than 20 women protects men against prostate cancer, academics find," The Daily Telegraph reports.The study in question included more than 1,500 men diagnosed with prostate cancer and a matched group of men without prostate cancer from the general population. Researchers then interviewed the men about their sexual activity. The study concluded that having more than 20 female partners over a man’s lifetime was associated with a decreased risk of prostate cancer, while having several male partners seemed to increase the risk.However, studies like this one cannot prove that ha...
Source: NHS News Feed - October 29, 2014 Category: Consumer Health News Tags: Lifestyle/exercise Cancer Source Type: news
STD may heighten risk of prostate cancer
Could a common sexually transmitted infection boost a man’s risk for prostate cancer? In a new study, Patricia Johnson, a professor of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA, explored the connection between prostate cancer and the parasite that causes trichomoniasis, the most common non-viral sexually transmitted infection in men and women. Johnson’s team discovered that the parasite, Trichomonas vaginalis, secretes a protein that stimulates the growth of prostate cells and also induces an inflammatory response, which the researchers suspect enhances the c...
Source: UCLA Newsroom: Health Sciences - May 28, 2014 Category: Universities & Medical Training Source Type: news
Prostate cancer linked to common STI
“Prostate cancer could be a sexually transmitted disease caused by a common infection,” The Independent reports. Researchers have found evidence of a link between the cancer and trichomoniasis – a common parasite that is passed on during unprotected sexual contact. A laboratory study found the parasite produces a protein similar to a human protein that is necessary for the immune system to function. However, the human protein had also been shown to be involved in the growth of cancers, as it causes inflammation. This is of potential concern as trichomoniasis causes no noticeable symptoms in up to half of...
Source: NHS News Feed - May 21, 2014 Category: Consumer Health News Tags: Cancer Source Type: news
Management Challenges in Trichomonas vaginalis InfectionManagement Challenges in Trichomonas vaginalis Infection
What are the optimal methods of diagnosis and treatment for Trichomonas vaginalis? Sexually Transmitted Infections (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 7, 2013 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
FDA approval and launch
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has announced the US Food and Drug Administration clearance and launch of the BD ProbeTec™ Trichomonas vaginalis Qx Amplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and vaginal samples as well as neat urine specimens to aid in the diagnosis of trichomoniasis on the BD Viper™ System with XTR™ Technology. You must sign in to continue reading this article Hide related content: Show related content read more...
Source: Pharmacy Europe - August 29, 2013 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Latest News Source Type: news
BD ProbeTec(TM) Trichomonas vaginalis Q(x) Assay Launches on the BD Viper(TM) System with XTR(TM) Technology in the United States
New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females BALTIMORE, Aug. 27, 2013 -- (Healthcare Sales & Marketing Network) -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (BDX), a leadin... Diagnostics, FDA, Product LaunchBD Diagnostics, BD , ProbeTec, trichomoniasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2013 Category: Pharmaceuticals Source Type: news
Researchers Identify Two Bacterial Communities Associated With Trichomonas Infection
A parasite that commonly causes sexually transmitted infections among women "cultivates" specific bacteria, according to new research carried out by David H. Martin, MD, Professor and Chief of Infectious Diseases at LSU Health Sciences Center New Orleans and his team. The parasite, called Trichomonas vaginalis is a fairly common sexually transmitted infection (STI) of the urogenital tract among women, affecting more than 160 million females around the world... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2013 Category: Consumer Health News Tags: Sexual Health / STDs Source Type: news
Bill Gates’s $100,000 Condom Challenge
WebMD Medical News By Tim Locke Reviewed by Rob Hicks, MD March 25, 2013 — The Bill & Melinda Gates Foundation is offering a $100,000 grant to anyone who can develop what’s being called the next generation of condom. The aim is to help curb unwanted pregnancies and the spread of sexually transmitted infections around the world. The Condom of the Future The foundation’s Grand Challenges in Global Health initiative says it is looking for the next-generation condom that “significantly preserves or enhances pleasure, in order to improve uptake and regular use.” This could mean safe, new...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 27, 2013 Category: Consumer Health News Authors: mreal197 Tags: WebMD News Source Type: news